Teneligliptin hydrobromide
| CAS No. | 906093-29-6 | Cat. No. | BCP12262 |
| Name | Teneligliptin hydrobromide | ||
| Synonyms | Teneligliptin HBr;MP-513 hydrobromide;MP513 hydrobromide; | ||
| Formula | 2(C22H30N6OS).5(HBr) | M. Wt | 1257.72 |
| Description | Teneligliptin hydrobromide is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM.Teneligliptin is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase-4 inhibitors or "gliptins". It is approved for use in Japan. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | DPP | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.